Clinical Trial Update: A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing morning injections of Toujeo versus Lantus in adults with Type 1 Diabetes Mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• TOUJEO (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2018-08-20